Characteristics of Patients With COVID-19 in Meta State, Colombia

Study Overview
=================
Brief Summary
-----------------
This observational study aims to collect detailed clinical information on confirmed or suspected patients of COVID-19 treated in hospitals from Meta State, Colombia. The objectives are: To establish the characteristics of patients and healthcare workers treated with COVID-19. To assess previous predisposing morbidity. To detail clinical factors associated with complications. To profile clinical indicators for severity and outcomes.

Detailed Description
-----------------
Hospital database and clinical charts in an electronic format of patients with suspected or confirmed COVID-19 will be reviewed to include in the study. Multiple centers from the eastern Colombian prairies caring for this population will participate to provide an understanding of the behavior of the epidemic and accurate clinical comprehension of the disease. Healthcare centers involved in providing an evaluation of patients infected with SARS-CoV-2 will be invited to participate. The study will focus on the routine or new treatment strategies provided and a large population of patients analyzed would be desirable. It will allow identifying the most relevant factors associated with clinical outcomes, complications, and prognosis, with an appropriate statistical methodology for the analysis of observational nature. Variables of individuals assisted will be recorded as well as the end results, such as baseline characteristics of individuals and disease, and main outcomes such as mortality, need for ICU attention, mechanical ventilation, and length of stay. These results will be used to promote an improvement in the quality of care and individual and cluster decisions in the region.

Official Title
-----------------
Evaluation of the Characteristics of Patients With Suspected or Confirmed of COVID-19 in Villavicencio and Meta State, Colombia

Conditions
-----------------
COVID, SARS-CoV 2, SARS Pneumonia, SARS (Disease), SARS (Severe Acute Respiratory Syndrome)

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients admitted to participant institutions with respiratory symptoms or diagnosed as compatible with COVID-19. Exclusion Criteria: None.

Ages Eligible for Study
-----------------
Maximum Age: 120 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Patients treated with COVID-19<br>All populations of patients admitted with COVID-19 in healthcare institutions involved. No intervention but standard care designed by national guidelines will be provided. | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Mortality | Death within 30 days of hospital admission | 30 days | 
| ICU admission | Need for intensive care unit admission | 30 days | 
| Mechanical ventilation | Need for intubation and invasive mechanical ventilation | 30 days | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| ICU length of stay | Duration of stay in the intensive care unit | 30 days | 
| Hospital length of stay | Duration of stay in hospitalization | 30 days | 
| Days of mechanical ventilation | Duration of mechanical ventilation included with intubation or tracheostomy | 30 days | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
COVID, SARS, Viral Pneumonia, SARS-CoV 2, Coronavirus